# Competitive Generic Therapies - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/competitive-generic-therapies/402bfb2a-4126-427d-9a19-4507e22c6b0e

> FDA guidance document: Competitive Generic Therapies. Issue date: October 05, 2022. Get complete insights and analysis.

---

## Details

- Title: Competitive Generic Therapies
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-10-05
- Last Changed: 2023-01-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-0065">FDA-2019-D-0065</a>

## Related Documents

- [Controlled Correspondence Related to Generic Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/controlled-correspondence-related-to-generic-drug-development/55babf6e-6cea-4e6c-80f6-3892feff9aab)
- [Orange Book Questions and Answers Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/orange-book-questions-and-answers-guidance-for-industry-guidance-for-industry/8492a175-773f-4d3e-a92c-aec1f10c8bda)
- [Good ANDA Submission Practices Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/good-anda-submission-practices-guidance-for-industry/c4f8f27a-3522-470b-8889-206366ebc0e7)